Sox transcription factors require selective interactions with oct4 and specific transactivation functions to mediate reprogramming

by Aksoy, I., Jauch, R., Eras, V., Chng, W.-B.A., Chen, J., Divakar, U., Ng, C.K.L., Kolatkar, P.R., Stanton, L.W.
Published 2014

Conversion of Sox17 into a pluripotency reprogramming factor by reengineering its association with Oct4 on DNA

by Jauch, R., Aksoy, I., Hutchins, A.P., Ng, C.K.L., Tian, X.F., Chen, J., Palasingam, P., Robson, P., Stanton, L.W., Kolatkar, P.R.
Published 2014

Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm

by Aksoy, I., Jauch, R., Chen, J., Dyla, M., Divakar, U., Bogu, G.K., Teo, R., Leng Ng, C.K., Herath, W., Lili, S., Hutchins, A.P., Robson, P., Kolatkar, P.R., Stanton, L.W.
Published 2014

Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency

by Chen, H, Aksoy, I, Gonnot, F, Osteil, P, Aubry, M, Hamela, C, Rognard, C, Hochard, A, Voisin, S, Fontaine, E, Mure, M, Afanassieff, M, Cleroux, E, Guibert, S, Chen, J, Vallot, C, Acloque, H, Genthon, C, Donnadieu, C, De Vos, J, Sanlaville, D, Guérin, J.-F, Weber, M, Stanton, L.W, Rougeulle, C, Pain, B, Bourillot, P.-Y, Savatier, P
Published 2020

Detection of chromosomal breakpoints in patients with developmental delay and speech disorders

by Utami K.H., Hillmer A.M., Aksoy I., Chew E.G.Y., Teo A.S.M., Zhang Z., Lee C.W.H., Chen P.J., Seng C.C., Ariyaratne P.N., Rouam S.L., Soo L.S., Yousoof S., Prokudin I., Peters G., Collins F., Wilson M., Kakakios A., Haddad G., Menuet A., Perche O., Tay S.K.H., Sung K.W.K., Ruan X., Ruan Y., Liu E.T., Briault S., Jamieson R.V., Davila S., Cacheux V.
Published 2018